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Abstract 
Background and objectives: - Amavata (Rheumatoid arthritis) is a most remarkable problem in the society in 
modern era. In Ayurveda, many approaches are in practice to treat Amavata but still it remains a challenging 
problem. Ayurveda considers ama as the root cause of disease amavata. Design: Double blind randomized 
interventional trial. Participants: age group of 20-60 yrs. Method: 60 patients were selected from OPD and IPD of 
A & U Tibbia college and hospital, Delhi. They were randomly divided in two groups. Bhallatakadi Churna with 
guda in Group A and Bhallatak guggulu in Group B administered for three months of duration with follow up at 
every fifteen days. Outcome measures:- The assessment of efficacy of drug was made through scoring of clinical 
features and Laboratory parameters i. e. RA factor, ASO titre. Results: Present study reflects that both regimes- 
Bhallatak churna with guda and Bhallatak guggulu, have given very good relief in sign and symptoms of Amavat, 
but in group B who received Bhallatak Guggul showed faster and better improvement. Conclusion:- Bhallatak 
Guggulu is safe, beneficial and very effective in management of Amavata and also in Rheumatoid arthritis.  
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Introduction:- 
Amavata is chronic systemic disease having 
painful multiple joint involvement. In Ayurveda 
Madhavakar(700AD) mentioned first the Amavata as a 
special disease entity and where ama as well as vata 
plays a predominant role in the samprapti 
(pathogenesis) of the disease (1). Rheumatoid arthritis 
is a chronic, progressive autoimmune arthropathy and is 
characterised by bilateral symmetrical involvement of 
joints with some systemic clinical menifestations. (2) 
Ayurveda is an ancient scientific medical 
knowledge in the world. So many Ayurvedic medicines 
had been described in Ayurveda for the treatment of 
Amavata (Rheumatoid arthritis). Amavata is a most 
remarkable problem in the society in modern era.  
Ayurveda considers ama as the root cause of 
disease amavata. Ama is a mucoid, slimy substance 
caused due to the malfunctioning of digestive and 
metabolic mechanisms. This ama is detrimental to 
srotas(body channels) due to its clogging capacity. 
While circulating in body along with vata it produces 
this agonising disease called amavata, which is very 
difficult to treat, and if not treated, leads to angavaikalya 
(deformities). (3) 
The prevalence rate of this disease is about 3% 
with a male to female ratio of 1:3. It occurs throughout 
the world in all climates and ethnic groups.  
The conceptual study on rheumatoid arthritis and 
amavata revealed that there is striking similarities 
between etiopathogenesis of RA and amavata, and it 
was found that basic pathology in RA is microvascular 
injury caused by inflammatory mediators, especially in 
synovium which is nothing srotavarodha and 
srotobhisyanda caused by ama in dhamanis of sleshma 
sthana specially sleshma dharana kala of joints.  
Several dreadful diseases are prevalent in medical 
science. The scope for therapeutic measures is limited 
even after extreme advancement of the modern 
biomedical science. The rheumatological disorder is a 
group of diseases that has no specific medical 
management in any type of therapeutics. In spite of the 
description of multiple drug therapy on Amavata in 
different classics of Ayurveda, potential and durable 
results are not found due to non-removal of the basic 
cause. Hence, special emphasis should be put into 
searching for a standard and suitable drug for Amavata.  
In ancient literature of Ayurveda specially in 
Vrihatrayi, various measures and medicinal 
preparations are described for treating articular diseases. 
The disease amavata is described elaborately for the 
first time by Madhav in seventh century only. 
Chakradutta has not only outlined the chikitsa 
siddhanta for the disease amavata for the first time but 
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has also been described several preparations for treating 
the disease. Hence, Ayurvedic medicine i. e. Bhallatak 
guggulu yoga has been selected from Yogaratnakar for 
clinical evaluation on the management of Amavata 
(Rheumatoid arthritis).  
The trial drug Bhallatak guggulu yoga conisits of 
four herbs i. e. Bhallatak, Guggulu, Haritaki and 
Krishna Tila. These herbs are not only excellent in 
doing deepana, and pachana functions but also 
comprising vyadhi nashak guna. (4) 
These drugs also have anti- inflammatory, 
immune modulatory, anti- oxidant anti- arthritic and 
cartilage protective activity. (5) 
In Ayurveda many approaches are in practice to 
treat amavata but still it remains a challenging problem. 
Hence, the study is planned for better management of 
Amavata patients with enhanced quality of life.  
 
Aims and Objectives 
The present research trial has been undertaken 
with the following objective.  
To validate Ayurvedic concept of rheumatology 
on scientific lines 
To evaluate efficacy of Bhallatak Guggulu Y oga 
in the management of Amavata.  
To develop safe and cost effective Ayurvedic 
drug for Rheumatoid arthritis.  
 
 
Material and methods 
Selection of cases 
 Total 60 cases divided in to two groups equally.  
Group A-This group of 30 patients were given 
Bhallatakadi churna with guda  
Group B-This group of 30 patients were given 
Bhallatak Guggulu.  
The drug for group A was given in dose of 2. 
5gm twice a day while Bhallatak guggul was given in 
the dose of 500mg TDS in group B.  
 
Source 
 Patients for the present study were screened out 
from the O. P. D. and I. P. D. of Kayachikitsa 
Department of A & U Tibbia College and Hospital, 
Karol Bagh, New Delhi.  
 
Age Group: between 20-60 years were selected.  
 
Study design: Double blind randomised 
interventional clinical trial.  
 
Inclusive criteria 
 Age—20-60 years 
 Patients of Amavata (Rheumatoid Arthritis) 
fulfilling the criteria of Clinical symptoms of 
Amavata mentioned in Ayurvedic classics.  
 Patient able to participate in the study and ready 
to follow the instruction  and consent for three 
months.  
 Exclusive Criteria 
 Age below 20 and above 60.  
 All complicated cases having any advanced 
deformity of rheumatoid arthritis.  
 Having cardiac diseases, pulmonary tuberculosis 
and pregnant woman.  
 Pittaja prakrati and summer season 
 
Criteria for assessment 
Subjective criteria: 
The results of therapy were assessed on the basis 
of clinical features of the disease Amavata, which are 
mentioned in Ayurvedic classic. The scoring pattern 
adopted for assessment of clinical features is as 
follows: 
(a) Angmarda (Bodyache)  
0= Absent 
1= Transiently present 
2= Present for long period  
3= Regular present 
(b) Aruchi (loss of appetite) 
0= Absent 
1= Present but not complained 
2= Present and complained 
3= Distressing in social life 
(c) Alasya (Listlessness) 
0= Absent 
1= Present but not effecting the life 
2= Present for such work which need more effort 
3= Present and effecting routine biological 
activity 
(d) Gaurav (Heaviness of body and joints) 
0= Absent 
1= Present but not complained 
2= Present and complained 
3= Distressing in social life 
(e) Trishna (thirst) 
0= Absent 
1= Only feeling 
(f) Jvara (fever) 
0= Absent 
1= only feeling 
2= Temp. Above normal but <100˚F 
3= Temp >100˚F 
(g) Apaki (Indigestion) 
0= Absent 
1= Only occasional and Transient 
2= Often and Transient 
3= Very often, presented with associated 
symptoms  
(h)Sandhishool (Pain in joints) 
0= No pain  
1= Mild pain of bearable nature, comes 
occasionally 
2= Moderate pain, but no difficulty in joint 
movement 
3= Slight difficulty in joint movements due to 
pain 
(i)Shoonta anganam 
0= No swelling  
1= Slight swelling  
2= Moderate swelling  
3= Severe swelling  
(j) Sandhi graha (stiffness of the joints) 
0= no stiffness or stiffness lasts for 5 min.  
1= 5 min to 1 hour 
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2= 1 to 2 hour 
3= >2 hour 
(k) Sparshasahayata (Tenderness of joints) 
0= No tenderness 
1= Subjective experience of tenderness 
2= Wincing of face on pressure 
3= Wincing of face with withdrawal of affected 
parts on pressure 
4= Resists to touch  
 
Objective Criteria: Normal range  
(a) RA factor(Rheumatoid arthritis factor) 0-20 
micro/ml 
(b) ASO Titre (Anti streptolysin O) upto 200 IU 
(c) CRP (C- Reactive protein) less than 1 
Observation and Results 
Out of 60 patients, maximum 85% patients were 
female, 36% patients in between the age of 5th decade, 
53% patients were hindu, 85% patients were married, 
56% were kapha pitta prakriti, 58% were Kroora koshta 
and 61% patients were non vegeterians; 8%patients 
showed positive family history and 92%patients did not 
show any family history. Maximum 100% patients had 
involvement of proximal interphalangeal (hand), MCP 
and wrist joint involvement.  
Effect of both Bhallatakadi churna with guda and 
Bhallatak guggulu on chief symptoms of Amavata is 
found to be statistically highly significant (p<0. 001)
(Table no-1). Also statistically highly significant (p<0. 
001) results were found on general syptoms such as 
sandhishoola, sandhigraha and sandhisparsha 
ashayata. (Table no-2).  
Table No 1: Effect of drug on symptoms of Amavata 
 
 
Table No 2: (Effect of drug on general symptoms) 
 
 
Effect of 
the drug 
on 
Group N Mean Dif. % of 
Change 
SD SE T P Remarks 
BT AT 
Angmarda A 30 2.23 0.00 2.23 100 0.63 0.4 19.54 <0.001 H.S. 
B 30 2.13 0.07 2.07 96.88 0.64 0.12 17.70 <0.001 H.S. 
Aruchi A 30 1.57 0.00 1.57 100 0.63 0.11 13.71 <0.001 H.S. 
B 30 1.57 0.00 1.57 100 0.57 0.10 15.10 <0.001 H.S. 
Trishna A 30 0.93 0.10 0.83 89.29 0.46 0.08 9.90 <0.001 H.S. 
B 30 0.80 0.03 0.77 95.83 0.43 0.08 9.76 <0.001 H.S. 
Alasya A 30 1.33 0.00 1.33 100 0.48 0.09 15.23 <0.001 H.S. 
B 30 1.17 0.03 1.13 97.14 0.35 0.06 17.95 <0.001 H.S. 
Gaurav A 30 2.27 0.00 2.27 100 0.52 0.10 23.84 <0.001 H.S. 
B 30 1.83 0.00 1.83 100 0.46 0.08 21.78 <0.001 H.S. 
Jvara A 30 1.37 0.10 1.27 92.68 0.45 0.08 15.43 <0.001 H.S. 
B 30 1.20 0.07 1.13 94.44 0.43 0.08 14.30 <0.001 H.S. 
Apaka A 30 1.90 0.00 1.90 100 0.55 0.10 19.00 <0.001 H.S. 
B 30 1.80 0.10 1.70 94.44 0.47 0.09 19.98 <0.001 H.S. 
Shoonta 
Anganam 
A 30 2.03 0.07 1.96 96.72 0.41 0.08 26.03 <0.001 H.S. 
B 30 1.50 0.07 1.43 95.56 0.50 0.09 15.58 <0.001 H.S. 
Effect of the 
drug on 
Group N Mean Dif. % of 
Change 
SD SE T P Remarks 
BT AT 
Sandhishool A 30 2.43 0.63 1.80 73.97 0.71 0.13 13.80 <0.001 H.S. 
B 30 2.07 0.13 1.93 93.55 0.37 0.07 29.00 <0.001 H.S. 
Sandhigraha A 30 2.50 0.13 2.47 94.67 0.61 0.11 21.08 <0.001 H.S. 
B 30 2.10 0.10 2.00 95.24 0.53 0.10 20.86 <0.001 H.S. 
A 30 1.93 0.43 1.50 77.59 0.57 0.10 14.35 <0.001 H.S. Sandhisparsha 
Asahyata  B 30 1.43 0.07 1.37 95.35 0.49 0.09 15.27 <0.001 H.S. 
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The effect of trial drug on RA factor, ASO titre and CRP was found to be highly significant (p<0. 001) both in group 
A as well as in group B, (Table no- 3) 
 
Table No 3: Effect of drug on objective parameters 
 
Effect of 
the drug 
on 
Group N Mean Dif. % of 
Change 
SD SE T P Remark 
BT AT 
RA Factor A 30 39.92 22.75 16.50 41.33 19.59 3.58 4.61 <0.001 H.S. 
B 30 24.55 9.75 14.81 60.30 30.77 5.62 2.64 <0.01 H.S. 
CRP (C- 
reactive 
protein) 
A 30 11.37 6.59 4.65 40.89 5.24 0.96 4.86 <0.001 H.S. 
B 30 15.34 5.92 9.42 61.42 22.36 4.08 2.31 <0.10 H.S. 
ASO Titre
(Anti 
streptolysin 
O) 
A 30 115.72 99.87 15.22 13.15 17.51 3.20 4.76 <0.10 H.S. 
B 30 101.91 68.46 33.45 32.82 105.83 19.32 1.73 >0.05 N.S. 
Discussion 
Maximum number of patients belonged to the age 
group of 41-50 years, which shows its predominance in 
the middle age group. This data is slightly in accordance 
with the modern findings, that the onset is most frequent 
during the fourth and fifth decades of life with 80% of 
all patients developing disease between the age of 35-50 
years. In this study, majority of the patients were female 
as compared to male. Textual references also reflect the 
predominance of rheumatoid arthritis in females. In this 
study, most of the patients had impaired agni, with 55 
patients (91. 67%) exhibiting mandagni, this mandagni 
leads to formation of ama (basis pathological unit) and 
mandagni also leads to mooda vata (impair anuloman 
of vata). Among 60 patients, 58(96. 67%) patients 
exhibiting constipated bowel because mandagni 
decrease the force and action of saman vayu and apana 
vayu. In this study, 17 patients (28. 33%) had krura 
kostha,  61. 67% had madhyam kostha, confirming 
dominance of either vata or kapha or both at kostha 
level in Amavata patients. These data also support the 
etiology of Amavata, mentioned in classics. 
Bhallatakadi churna comprises of Haritaki, Bhallatak, 
Tila and Guda. Haritaki having properties like   
amapachan, sroto vibandhanashaka and dosha 
anulomana. Bhallataka having tikshna and ushna guna, 
anuloman, deepan, pachan  properties helps in 
stimulating  jatharagni. Krishna Til causing  
agnipustikrit and kaphapitta nashak properties which 
are antagonistic to Ama and is very much required in 
the conditions like Amavata. (6) Guda having 
properties like anabhishandi  and agnipushtikrita helps 
in ameliorating the symptoms of Amavata. Also in 
group B (Bhallataka guggul), guggul is having sukshma, 
tikshna and sara properties which is sufficient for the 
deep penetration of both the srotas resulting in pacifying  
the symptom of Amavata and also play an important 
role in breaking the pathogenesis of disease Amavata.  
 
Conclusion 
Lastly, it can be concluded that Amavata looks 
similar to Rheumatoid Arthritis in its clinical 
appearance. Bhallatak Guggulu Y oga mentioned in 
Yogaratnakar showed a substantial relief in all 
parameters whether subjective or clinical of the 
Amavata supporting its anti-inflammatory and anti 
arthritic action. Present study reflects that both regimens
-Bhallatakadi churna with guda and Bhallatak guggulu, 
have given very good relief in signs and symptoms of  
Amavata, but in group B who received Bhallatak 
Guggulu showed faster and better improvement.  
 
References 
1. Upadhyaya Y. N. , Sanskrit Commentary by Sri 
Vijayarakshita and Sri Kanthadatta. Madhava Nidana 
of Madhavakara, 3rd edi. Varanasi; Chaukamba 
Sanskrit Series;1970, 105-110pg.  
2. Arend W. P. Physiology of cytokine pathways in 
Rheumatoid arthritis. 4th edi, 2001;101-106pg.  
3. Dwarkanath. C. Introduction to Kayachikitsa. 3rd edi. 
Varanasi; Bharati publication;1986;95pg 
4. Vaidyaraj Datto Borkar. Yogaratnakar. 6th edi. Pune; 
Gajanan book depot prakashan.  
5. Raghumathanand K, Roma Mitra. Pharmacognosy of 
Indigenous drugs. 7th edi. , New Delhi, CCRAS, 
2001; 
6. Brahmashankar Mishra. Bhavaprakash Nighantu- 
Vidyotini Hindi Commentary, 6th edi, Varanasi, 
Chaukambha Sanskrit Sansthana.  
 
***** 
